{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T08:06:45Z","timestamp":1790928405183,"version":"4.1.0"},"reference-count":264,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003981","name":"Agenzia Spaziale Italiana","doi-asserted-by":"publisher","award":["N. 2023\\u20137-HH.0 CUP F13C23000050005"],"award-info":[{"award-number":["N. 2023\\u20137-HH.0 CUP F13C23000050005"]}],"id":[{"id":"10.13039\/501100003981","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012352","name":"Universita degli Studi di Milano","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["101086397"],"award-info":[{"award-number":["101086397"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.phrs.2026.108278","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T23:29:29Z","timestamp":1780356569000},"page":"108278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Beyond weight loss: How metabolism in human adipocytes is shaped by GLP-1R agonists and dual GIPR\/GLP-1R agonists"],"prefix":"10.1016","volume":"230","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-5395-8140","authenticated-orcid":false,"given":"Roberto","family":"Curto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2836-6185","authenticated-orcid":false,"given":"Claudia","family":"Giglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4599-8487","authenticated-orcid":false,"given":"Rossella","family":"Cannarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5096-8411","authenticated-orcid":false,"given":"Hygerta","family":"Berisha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5202-9153","authenticated-orcid":false,"given":"Reham","family":"Hattab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosita A.","family":"Condorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro La","family":"Vignera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6950-335X","authenticated-orcid":false,"given":"Aldo E.","family":"Calogero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2254-8881","authenticated-orcid":false,"given":"Paolo","family":"Magni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2026.108278_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101850","article-title":"Trends and predictions of malnutrition and obesity in 204 countries and territories: an analysis of the Global Burden of Disease Study 2019","volume":"57","author":"Chong","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.phrs.2026.108278_bib2","unstructured":"World Health Organization, \u201cWHO acceleration plan to stop obesity.\u201d Accessed: Dec. 02, 2025. [Online]. Available: \u3008https:\/\/www.who.int\/publications\/i\/item\/9789240075634\u3009."},{"key":"10.1016\/j.phrs.2026.108278_bib3","unstructured":"World Obesity Federation, \u201cWorld Obesity Atlas 2022 | World Obesity Federation.\u201d Accessed: Feb. 21, 2026. [Online]. Available: \u3008https:\/\/www.worldobesity.org\/resources\/resource-library\/world-obesity-atlas-2022\u3009."},{"key":"10.1016\/j.phrs.2026.108278_bib4","unstructured":"World Health Organization, \u201cObesity and overweight.\u201d Accessed: Jan. 11, 2026. [Online]. Available: \u3008https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight\u3009."},{"issue":"5","key":"10.1016\/j.phrs.2026.108278_bib5","doi-asserted-by":"crossref","first-page":"776","DOI":"10.3390\/nu17050776","article-title":"Nutrition and Lifestyle Interventions in Managing Dyslipidemia and Cardiometabolic Risk","volume":"17","author":"Berisha","year":"2025","journal-title":"Nutrients"},{"issue":"10","key":"10.1016\/j.phrs.2026.108278_bib6","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.3390\/nu14102040","article-title":"Adherence to the Mediterranean Diet: Impact of Geographical Location of the Observations","volume":"14","author":"Mattavelli","year":"2022","journal-title":"Nutrients"},{"issue":"8","key":"10.1016\/j.phrs.2026.108278_bib7","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.3390\/nu15081844","article-title":"Adherence to Mediterranean Diet: A Population-Based Longitudinal Cohort Study","volume":"15","author":"Mattavelli","year":"2023","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.phrs.2026.108278_bib8","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.3390\/nu13061804","article-title":"Reduction of Cardio-Metabolic Risk and Body Weight through a Multiphasic Very-Low Calorie Ketogenic Diet Program in Women with Overweight\/Obesity: A Study in a Real-World Setting","volume":"13","author":"Tragni","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.phrs.2026.108278_bib9","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.66500","article-title":"Long-Term Effectiveness and Outcomes of Bariatric Surgery: A Comprehensive Review of Current Evidence and Emerging Trends","author":"Ram Sohan","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.phrs.2026.108278_bib10","author":"Bray","year":"2000","journal-title":"Hist. Rev. Steps Missteps Discov. Anti-Obes. Drugs"},{"issue":"4","key":"10.1016\/j.phrs.2026.108278_bib11","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1124\/pr.117.014803","article-title":"Anti-Obesity Therapy: from Rainbow Pills to Polyagonists","volume":"70","author":"M\u00fcller","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.phrs.2026.108278_bib12","author":"Tchang","year":"2000","journal-title":"Pharmacol. Treat. Overweight Obes. Adults"},{"issue":"1","key":"10.1016\/j.phrs.2026.108278_bib13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/138955707779317894","article-title":"Hypothalamic Neuropeptide Systems as Targets for Potential Anti-Obesity Drugs","volume":"7","author":"Dozio","year":"2007","journal-title":"Mini-Rev. Med. Chem."},{"issue":"12","key":"10.1016\/j.phrs.2026.108278_bib14","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/d41573-025-00155-2","article-title":"The evolution of the obesity drug market","volume":"24","author":"Recasens-Alvarez","year":"2025","journal-title":"Nat. Rev. Drug. Discov."},{"issue":"7","key":"10.1016\/j.phrs.2026.108278_bib15","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1001\/jama.2015.9676","article-title":"Efficacy of liraglutide for weight loss among patients with type 2 diabetes: The SCALE diabetes randomized clinical trial","volume":"314","author":"Davies","year":"2015","journal-title":"JAMA - J. Am. Med. Assoc."},{"issue":"10","key":"10.1016\/j.phrs.2026.108278_bib16","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1038\/s41591-022-02026-4","article-title":"Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial","volume":"28","author":"Garvey","year":"2022","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.phrs.2026.108278_bib17","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide Once Weekly for the Treatment of Obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"New. Engl. J. Med."},{"issue":"10313","key":"10.1016\/j.phrs.2026.108278_bib18","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/S0140-6736(21)02188-7","article-title":"Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial","volume":"398","author":"Del Prato","year":"2021","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.phrs.2026.108278_bib19","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa2107519","article-title":"Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes","volume":"385","author":"Fr\u00edas","year":"2021","journal-title":"New. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.phrs.2026.108278_bib20","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1177\/23969873241234238","article-title":"Risk of major adverse cardiovascular events and stroke associated with treatment with GLP-1 or the dual GIP\/GLP-1 receptor agonist tirzepatide for type 2 diabetes: A systematic review and meta-analysis","volume":"9","author":"Stefanou","year":"2024","journal-title":"Eur. Stroke J."},{"issue":"20","key":"10.1016\/j.phrs.2026.108278_bib21","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/j.jacc.2025.08.027","article-title":"Cardiovascular Effects and Tolerability of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of 99,599 Patients","volume":"86","author":"Galli","year":"2025","journal-title":"J. Am. Coll. Cardiol."},{"issue":"13","key":"10.1016\/j.phrs.2026.108278_bib22","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJMoa2404881","article-title":"Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity","volume":"391","author":"Malhotra","year":"2024","journal-title":"New. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.phrs.2026.108278_bib23","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1056\/NEJMoa2401943","article-title":"Tirzepatide for Metabolic Dysfunction\u2013Associated Steatohepatitis with Liver Fibrosis","volume":"391","author":"Loomba","year":"2024","journal-title":"New. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.phrs.2026.108278_bib24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S2213-8587(24)00271-7","article-title":"Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials","volume":"13","author":"Badve","year":"2025","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.phrs.2026.108278_bib25","doi-asserted-by":"crossref","unstructured":"D.J. Drucker, \u201cThe biology of incretin hormones,\u201d Mar. 2006. doi: 10.1016\/j.cmet.2006.01.004.","DOI":"10.1016\/j.cmet.2006.01.004"},{"issue":"1","key":"10.1016\/j.phrs.2026.108278_bib26","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-024-02203-4","article-title":"Evidence that tirzepatide protects against diabetes-related cardiac damages","volume":"23","author":"Taktaz","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"issue":"7","key":"10.1016\/j.phrs.2026.108278_bib27","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/ejhf.3644","article-title":"Cardioprotective effects of semaglutide on isolated human ventricular myocardium","volume":"27","author":"Krammer","year":"2025","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.phrs.2026.108278_bib28","doi-asserted-by":"crossref","unstructured":"L. Scheja and J. Heeren, \u201cThe endocrine function of adipose tissues in health and cardiometabolic disease,\u201d Sep. 01, 2019, Nature Publishing Group. doi: 10.1038\/s41574-019-0230-6.","DOI":"10.1038\/s41574-019-0230-6"},{"key":"10.1016\/j.phrs.2026.108278_bib29","doi-asserted-by":"crossref","unstructured":"J.J. Holst, \u201cThe physiology of glucagon-like peptide 1,\u201d Oct. 2007. doi: 10.1152\/physrev.00034.2006.","DOI":"10.1152\/physrev.00034.2006"},{"issue":"18","key":"10.1016\/j.phrs.2026.108278_bib30","doi-asserted-by":"crossref","first-page":"8641","DOI":"10.1073\/pnas.89.18.8641","article-title":"Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1","volume":"89","author":"Thorens","year":"1992","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2026.108278_bib31","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41392-024-01931-z","article-title":"Glucagon-like peptide-1 receptor: mechanisms and advances in therapy","volume":"9","author":"Zheng","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"2","key":"10.1016\/j.phrs.2026.108278_bib32","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3390\/molecules28020751","article-title":"GLP-1R Signaling and Functional Molecules in Incretin Therapy","volume":"28","author":"Wan","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.phrs.2026.108278_bib33","article-title":"GLP-1 and GIP receptor signaling in beta cells \u2013 A review of receptor interactions and co-stimulation","volume":"151","author":"Mayendraraj","year":"2022","journal-title":"Pept. (N. Y. )."},{"issue":"1","key":"10.1016\/j.phrs.2026.108278_bib34","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.bcp.2014.10.015","article-title":"Agonist-induced internalisation of the glucagon-like peptide-1 receptor is mediated by the G\u03b1q pathway","volume":"93","author":"Thompson","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phrs.2026.108278_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.678055","article-title":"The Interplay of Glucagon-Like Peptide-1 Receptor Trafficking and Signalling in Pancreatic Beta Cells","volume":"12","author":"Marzook","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)."},{"issue":"7","key":"10.1016\/j.phrs.2026.108278_bib36","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1111\/febs.17338","article-title":"\u201cArrestin-independent internalization of the <scp>GLP<\/scp> -1 receptor is facilitated by a <scp>GRK<\/scp>, clathrin, and caveolae-dependent mechanism,\u201d","volume":"292","author":"Von Moo","year":"2025","journal-title":"FEBS J."},{"issue":"3","key":"10.1016\/j.phrs.2026.108278_bib37","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1074\/jbc.M109.067207","article-title":"GLP-1 mediates antiapoptotic effect by phosphorylating bad through a \u03b2-arrestin 1-mediated ERK1\/2 activation in pancreatic \u03b2-cells","volume":"285","author":"Quoyer","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.phrs.2026.108278_bib38","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.tips.2025.03.003","article-title":"Structural pharmacology and mechanisms of GLP-1R signaling","volume":"46","author":"Zhou","year":"2025","journal-title":"Trends Pharmacol. Sci."},{"issue":"7694","key":"10.1016\/j.phrs.2026.108278_bib39","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nature25773","article-title":"Phase-plate cryo-EM structure of a biased agonist-bound human GLP-1 receptor\u2013Gs complex","volume":"555","author":"Liang","year":"2018","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.phrs.2026.108278_bib40","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41467-021-27760-0","article-title":"Dynamics of GLP-1R peptide agonist engagement are correlated with kinetics of G protein activation","volume":"13","author":"Deganutti","year":"2022","journal-title":"Nat. Commun."},{"issue":"7657","key":"10.1016\/j.phrs.2026.108278_bib41","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nature22394","article-title":"Cryo-EM structure of the activated GLP-1 receptor in complex with a G protein","volume":"546","author":"Zhang","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2026.108278_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114150","article-title":"Evaluation of biased agonism mediated by dual agonists of the GLP-1 and glucagon receptors","volume":"180","author":"Darbalaei","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"8","key":"10.1016\/j.phrs.2026.108278_bib43","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1111\/j.1476-5381.2010.00834.x","article-title":"The major determinant of exendin-4\/glucagon-like peptide 1 differential affinity at the rat glucagon-like peptide 1 receptor N-terminal domain is a hydrogen bond from SER-32 of exendin-4","volume":"160","author":"Mann","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2026.108278_bib44","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1021\/acsptsci.0c00022","article-title":"The Influence of Peptide Context on Signaling and Trafficking of Glucagon-like Peptide-1 Receptor Biased Agonists","volume":"3","author":"Fang","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.phrs.2026.108278_bib45","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.2147\/DDDT.S470826","article-title":"Clinical Pharmacokinetics of Semaglutide: A Systematic Review","volume":"18","author":"Yang","year":"2024","journal-title":"Drug. Des. Devel. Ther."},{"issue":"7","key":"10.1016\/j.phrs.2026.108278_bib46","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nm727","article-title":"Inhibition of gastric inhibitory polypeptide signaling prevents obesity","volume":"8","author":"Miyawaki","year":"2002","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.phrs.2026.108278_bib47","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.2337\/diabetes.54.8.2436","article-title":"Chemical Ablation of Gastric Inhibitory Polypeptide Receptor Action by Daily (Pro3)GIP Administration Improves Glucose Tolerance and Ameliorates Insulin Resistance and Abnormalities of Islet Structure in Obesity-Related Diabetes","volume":"54","author":"Gault","year":"2005","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.phrs.2026.108278_bib48","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1038\/oby.2008.393","article-title":"Glucose-dependent insulinotropic polypeptide (GIP) stimulates transepithelial glucose transport","volume":"16","author":"Singh","year":"2008","journal-title":"Obesity"},{"issue":"9","key":"10.1016\/j.phrs.2026.108278_bib49","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.2337\/db17-0480","article-title":"The Gluco- and Liporegulatory and Vasodilatory Effects of Glucose-Dependent Insulinotropic Polypeptide (GIP) Are Abolished by an Antagonist of the Human GIP Receptor","volume":"66","author":"Asmar","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2026.108278_bib50","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1152\/ajpendo.00347.2016","article-title":"Role of Adipose Tissue Nutrient\/Vitamin Metabolism in Physiological and Altered Metabolic Settings Glucose-dependent insulinotropic polypeptide promotes lipid deposition in subcutaneous adipocytes in obese type 2 diabetes patients: a maladaptive response","volume":"312","author":"Sravan","year":"2017","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2026.108278_bib51","doi-asserted-by":"crossref","unstructured":"L.L. Baggio and D.J. Drucker, \u201cGlucagon-like peptide-1 receptor co-agonists for treating metabolic disease,\u201d Apr. 01, 2021, Elsevier GmbH. doi: 10.1016\/j.molmet.2020.101090.","DOI":"10.1016\/j.molmet.2020.101090"},{"issue":"1","key":"10.1016\/j.phrs.2026.108278_bib52","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0167-0115(94)90136-8","article-title":"The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7\u201337) in normal and diabetic subjects","volume":"51","author":"Elahi","year":"1994","journal-title":"Regul. Pept."},{"issue":"2","key":"10.1016\/j.phrs.2026.108278_bib53","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-2265.2008.03451.x","article-title":"Effects of peripheral administration of synthetic human glucose-dependent insulinotropic peptide (GIP) on energy expenditure and subjective appetite sensations in healthy normal weight subjects and obese patients with type 2 diabetes","volume":"71","author":"Daousi","year":"2009","journal-title":"Clin. Endocrinol. (Oxf. )."},{"issue":"4","key":"10.1016\/j.phrs.2026.108278_bib54","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.2337\/db10-1332","article-title":"GIP does not potentiate the antidiabetic effects of GLP-1 in hyperglycemic patients with type 2 diabetes","volume":"60","author":"Mentis","year":"2011","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.phrs.2026.108278_bib55","doi-asserted-by":"crossref","first-page":"588","DOI":"10.2337\/dc19-0578","article-title":"No Acute Effects of Exogenous Glucose-Dependent Insulinotropic Polypeptide on Energy Intake, Appetite, or Energy Expenditure When Added to Treatment With a Long-Acting Glucagon-Like Peptide 1 Receptor Agonist in Men With Type 2 Diabetes","volume":"43","author":"Bergmann","year":"2020","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.phrs.2026.108278_bib56","doi-asserted-by":"crossref","first-page":"285","DOI":"10.14740\/jocmr6231","article-title":"Comparative Efficacy of Tirzepatide vs. Semaglutide in Reducing Body Weight in Humans: A Systematic Review and Meta-Analysis of Clinical Trials and Real-World Data","volume":"17","author":"Aamir","year":"2025","journal-title":"J. Clin. Med. Res."},{"issue":"13","key":"10.1016\/j.phrs.2026.108278_bib57","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2116506119","article-title":"Structural determinants of dual incretin receptor agonism by tirzepatide","volume":"119","author":"Sun","year":"2022","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"17","key":"10.1016\/j.phrs.2026.108278_bib58","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.140532","article-title":"Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist","volume":"5","author":"Willard","year":"2020","journal-title":"JCI Insight"},{"issue":"2","key":"10.1016\/j.phrs.2026.108278_bib59","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s42255-023-00966-w","article-title":"A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings","volume":"6","author":"V\u00e9niant","year":"2024","journal-title":"Nat. Metab."},{"issue":"6\u20137","key":"10.1016\/j.phrs.2026.108278_bib60","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ejcb.2013.06.001","article-title":"Adipocyte and adipogenesis","volume":"92","author":"Ali","year":"2013","journal-title":"Eur. J. Cell. Biol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108278_bib61","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/19491034.2016.1197442","article-title":"Organization of nuclear architecture during adipocyte differentiation","volume":"7","author":"Char\u00f3","year":"2016","journal-title":"Nucleus"},{"issue":"3","key":"10.1016\/j.phrs.2026.108278_bib62","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00018-022-04169-6","article-title":"Regulatory mechanisms of the early phase of white adipocyte differentiation: an overview","volume":"79","author":"Audano","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"issue":"1\u20132","key":"10.1016\/j.phrs.2026.108278_bib63","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cell.2013.12.012","article-title":"What We Talk About When We Talk About Fat","volume":"156","author":"Rosen","year":"2014","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.phrs.2026.108278_bib64","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.numecd.2006.07.009","article-title":"The role of brown adipose tissue in human obesity","volume":"16","author":"Cinti","year":"2006","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"10","key":"10.1016\/j.phrs.2026.108278_bib65","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.2337\/db19-0308","article-title":"Cellular Origins of Beige Fat Cells Revisited","volume":"68","author":"Shao","year":"2019","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.phrs.2026.108278_bib66","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF00210629","article-title":"Transcription, adipocyte differentiation, and obesity","volume":"74","author":"Auwerx","year":"1996","journal-title":"J. Mol. Med."},{"issue":"9","key":"10.1016\/j.phrs.2026.108278_bib67","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1101\/gad.5.9.1538","article-title":"Regulated expression of three C\/EBP isoforms during adipose conversion of 3T3-L1 cells","volume":"5","author":"Cao","year":"1991","journal-title":"Genes. Dev."},{"issue":"1","key":"10.1016\/j.phrs.2026.108278_bib68","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1101\/gad.948702","article-title":"C\/EBP\u03b1 induces adipogenesis through PPAR\u03b3: a unified pathway","volume":"16","author":"Rosen","year":"2002","journal-title":"Genes. Dev."},{"key":"10.1016\/j.phrs.2026.108278_bib69","doi-asserted-by":"crossref","unstructured":"G.C. Rivera-Gonzalez, E.G. Butka, C.E. Gonzalez, W. Kong, K. Jindal, and S.A. Morris, \u201cSingle-cell lineage tracing reveals hierarchy and mechanism of adipocyte precursor maturation,\u201d Jun. 04, 2023. doi: 10.1101\/2023.06.01.543318.","DOI":"10.1101\/2023.06.01.543318"},{"issue":"3","key":"10.1016\/j.phrs.2026.108278_bib70","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1152\/physrev.1998.78.3.783","article-title":"Understanding Adipocyte Differentiation","volume":"78","author":"GREGOIRE","year":"1998","journal-title":"Physiol. Rev."},{"issue":"5","key":"10.1016\/j.phrs.2026.108278_bib71","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1177\/1535370215619041","article-title":"The increasingly complex regulation of adipocyte differentiation","volume":"241","author":"Poulos","year":"2016","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.phrs.2026.108278_bib72","series-title":"Comprehensive Physiology","first-page":"1151","article-title":"Hormonal Regulation of Adipogenesis","author":"Lee","year":"2017"},{"issue":"10","key":"10.1016\/j.phrs.2026.108278_bib73","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/BF03344048","article-title":"Adipose tissue hormones","volume":"25","author":"Guerre-Millo","year":"2002","journal-title":"J. Endocrinol. Invest."},{"issue":"12","key":"10.1016\/j.phrs.2026.108278_bib74","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.2337\/diab.28.12.1141","article-title":"Gastric Inhibitory Polypeptide Enhanced Lipoprotein Lipase Activity in Cultured Preadipocytes","volume":"28","author":"Eckel","year":"1979","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.phrs.2026.108278_bib75","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1210\/endo.139.9.6288","article-title":"Functional GIP Receptors Are Present on Adipocytes","volume":"139","author":"Yip","year":"1998","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.phrs.2026.108278_bib76","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1053\/j.gastro.2007.09.005","article-title":"Glucose-Dependent Insulinotropic Polypeptide Enhances Adipocyte Development and Glucose Uptake in Part Through Akt Activation","volume":"133","author":"Song","year":"2007","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.phrs.2026.108278_bib77","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1194\/jlr.M012203","article-title":"Adipocyte expression of the glucose-dependent insulinotropic polypeptide receptor involves gene regulation by PPAR\u03b3 and histone acetylation","volume":"52","author":"Kim","year":"2011","journal-title":"J. Lipid Res."},{"issue":"11","key":"10.1016\/j.phrs.2026.108278_bib78","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1038\/ijo.2008.148","article-title":"Functional expression of glucose-dependent insulinotropic polypeptide receptors is coupled to differentiation in a human adipocyte model","volume":"32","author":"Weaver","year":"2008","journal-title":"Int. J. Obes."},{"issue":"9","key":"10.1016\/j.phrs.2026.108278_bib79","doi-asserted-by":"crossref","first-page":"6421","DOI":"10.1074\/jbc.M111.310342","article-title":"Regulation of Adipocyte Formation by GLP-1\/GLP-1R Signaling","volume":"287","author":"Challa","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.phrs.2026.108278_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160212","article-title":"Glucagon Like Peptide-1 Promotes Adipocyte Differentiation via the Wnt4 Mediated Sequestering of Beta-Catenin","volume":"11","author":"Liu","year":"2016","journal-title":"PLoS. One"},{"issue":"6","key":"10.1016\/j.phrs.2026.108278_bib81","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.3892\/ijmm.2013.1350","article-title":"Glucagon-like peptide 1 regulates adipogenesis in 3T3-L1 preadipocytes","volume":"31","author":"YANG","year":"2013","journal-title":"Int. J. Mol. Med."},{"issue":"3","key":"10.1016\/j.phrs.2026.108278_bib82","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1159\/000478872","article-title":"GLP-1\/GLP-1R Signaling in Regulation of Adipocyte Differentiation and Lipogenesis","volume":"42","author":"Chen","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"issue":"7","key":"10.1016\/j.phrs.2026.108278_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.psj.2024.103766","article-title":"Glucagon-like peptide-1 analog liraglutide reduces fat deposition in chicken adipocytes","volume":"103","author":"Zhang","year":"2024","journal-title":"Poult. Sci."},{"issue":"11","key":"10.1016\/j.phrs.2026.108278_bib84","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1111\/bph.13481","article-title":"Effects of glucagon-like peptide-1 on the differentiation and metabolism of human adipocytes","volume":"173","author":"El Bekay","year":"2016","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108278_bib85","doi-asserted-by":"crossref","first-page":"581","DOI":"10.37349\/etat.2024.00237","article-title":"Comparison of primary and passaged tumor cell cultures and their application in personalized medicine","volume":"5","author":"Pipiya","year":"2024","journal-title":"Explor. Target. Antitumor Ther."},{"issue":"12","key":"10.1016\/j.phrs.2026.108278_bib86","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.3390\/nu13124271","article-title":"Cameroonian Spice Extracts Modulate Molecular Mechanisms Relevant to Cardiometabolic Diseases in SW 872 Human Liposarcoma Cells","volume":"13","author":"Atchan Nwakiban","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.phrs.2026.108278_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2024.107452","article-title":"Unravelling molecular mechanisms in atherosclerosis using cellular models and omics technologies","volume":"158","author":"Kardassis","year":"2025","journal-title":"Vasc. Pharmacol."},{"issue":"5","key":"10.1016\/j.phrs.2026.108278_bib88","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s42255-023-00786-y","article-title":"Physiological and pathological roles of lipogenesis","volume":"5","author":"Jeon","year":"2023","journal-title":"Nat. Metab."},{"issue":"1","key":"10.1016\/j.phrs.2026.108278_bib89","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1146\/annurev.nutr.27.061406.093734","article-title":"Regulation of Lipolysis in Adipocytes","volume":"27","author":"Duncan","year":"2007","journal-title":"Annu. Rev. Nutr."},{"issue":"5","key":"10.1016\/j.phrs.2026.108278_bib90","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1042\/BCJ20190468","article-title":"Adipocyte lipolysis: from molecular mechanisms of regulation to disease and therapeutics","volume":"477","author":"Yang","year":"2020","journal-title":"Biochem. J."},{"issue":"3","key":"10.1016\/j.phrs.2026.108278_bib91","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41574-019-0280-9","article-title":"The effects of growth hormone on adipose tissue: old observations, new mechanisms","volume":"16","author":"Kopchick","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108278_bib92","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11154-021-09687-5","article-title":"Leptin as a key regulator of the adipose organ","volume":"23","author":"Pic\u00f3","year":"2022","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"2","key":"10.1016\/j.phrs.2026.108278_bib93","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2265.2005.02195.x","article-title":"Free and bound plasma leptin in normal weight and obese men and women: relationship with body composition, resting energy expenditure, insulin-sensitivity, lipid profile and macronutrient preference","volume":"62","author":"Magni","year":"2005","journal-title":"Clin. Endocrinol. (Oxf. )."},{"key":"10.1016\/j.phrs.2026.108278_bib94","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2019.00413","article-title":"Glucagon Receptor Signaling and Lipid Metabolism","volume":"10","author":"Galsgaard","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.phrs.2026.108278_bib95","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.587189","article-title":"ChREBP-Mediated Regulation of Lipid Metabolism: Involvement of the Gut Microbiota, Liver, and Adipose Tissue","volume":"11","author":"Iizuka","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)."},{"issue":"15","key":"10.1016\/j.phrs.2026.108278_bib96","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.129397","article-title":"SREBP-regulated adipocyte lipogenesis is dependent on substrate availability and redox modulation of mTORC1","volume":"4","author":"Crewe","year":"2019","journal-title":"JCI Insight"},{"issue":"12","key":"10.1016\/j.phrs.2026.108278_bib97","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/ijo.2012.21","article-title":"Liver X receptors and fat cell metabolism","volume":"36","author":"Laurencikiene","year":"2012","journal-title":"Int. J. Obes."},{"issue":"16","key":"10.1016\/j.phrs.2026.108278_bib98","doi-asserted-by":"crossref","first-page":"5989","DOI":"10.1128\/MCB.22.16.5989-5999.2002","article-title":"Microarray Analyses during Adipogenesis: Understanding the Effects of Wnt Signaling on Adipogenesis and the Roles of Liver X Receptor \u03b1 in Adipocyte Metabolism","volume":"22","author":"Ross","year":"2002","journal-title":"Mol. Cell. Biol."},{"issue":"9","key":"10.1016\/j.phrs.2026.108278_bib99","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1210\/jc.2005-0399","article-title":"Upstream Transcription Factor-1 Gene Polymorphism Is Associated with Increased Adipocyte Lipolysis","volume":"90","author":"Hoffstedt","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.phrs.2026.108278_bib100","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1161\/CIRCGENETICS.108.840421","article-title":"Functional Variant Disrupts Insulin Induction of USF1","volume":"2","author":"Naukkarinen","year":"2009","journal-title":"Circ. Cardiovasc. Genet."},{"issue":"2","key":"10.1016\/j.phrs.2026.108278_bib101","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0024-3205(99)00314-8","article-title":"GIF biology and fat metabolism","volume":"66","author":"Yip","year":"1999","journal-title":"Life Sci."},{"issue":"12","key":"10.1016\/j.phrs.2026.108278_bib102","doi-asserted-by":"crossref","first-page":"8557","DOI":"10.1074\/jbc.M609088200","article-title":"Activation of Lipoprotein Lipase by Glucose-dependent Insulinotropic Polypeptide in Adipocytes","volume":"282","author":"Kim","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.phrs.2026.108278_bib103","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1194\/jlr.M006841","article-title":"GIP increases human adipocyte LPL expression through CREB and TORC2-mediated trans-activation of the LPL gene","volume":"51","author":"Kim","year":"2010","journal-title":"J. Lipid Res."},{"issue":"19","key":"10.1016\/j.phrs.2026.108278_bib104","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1128\/MCB.00256-14","article-title":"A Naturally Occurring GIP Receptor Variant Undergoes Enhanced Agonist-Induced Desensitization, Which Impairs GIP Control of Adipose Insulin Sensitivity","volume":"34","author":"Mohammad","year":"2014","journal-title":"Mol. Cell. Biol."},{"issue":"5\u20136","key":"10.1016\/j.phrs.2026.108278_bib105","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000177467","article-title":"Effects of Gastric Inhibitory Polypeptide on Glucose and Lipid Metabolism of Isolated Rat Adipocytes","volume":"32","author":"Hauner","year":"1988","journal-title":"Ann. Nutr. Metab."},{"issue":"1","key":"10.1016\/j.phrs.2026.108278_bib106","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1210\/endo.140.1.6464","volume":"140","author":"McIntosh","year":"1999","journal-title":"Endocrinology"},{"issue":"7","key":"10.1016\/j.phrs.2026.108278_bib107","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/oby.2006.129","article-title":"Glucose-Dependent Insulinotropic Polypeptide Modulates Adipocyte Lipolysis and Reesterification","volume":"14","author":"Getty-Kaushik","year":"2006","journal-title":"Obesity"},{"issue":"1","key":"10.1016\/j.phrs.2026.108278_bib108","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cmet.2024.11.003","article-title":"The GIP receptor activates futile calcium cycling in white adipose tissue to increase energy expenditure and drive weight loss in mice","volume":"37","author":"Yu","year":"2025","journal-title":"Cell. Metab."},{"issue":"5924","key":"10.1016\/j.phrs.2026.108278_bib109","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/304368a0","article-title":"Exon duplication and divergence in the human preproglucagon gene","volume":"304","author":"Bell","year":"1983","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.phrs.2026.108278_bib110","doi-asserted-by":"crossref","first-page":"354","DOI":"10.4093\/dmj.2023.0277","article-title":"Glucagon-Like Peptide-1: New Regulator in Lipid Metabolism","volume":"48","author":"Bu","year":"2024","journal-title":"Diabetes Metab. J."},{"issue":"1","key":"10.1016\/j.phrs.2026.108278_bib111","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1677\/jme.1.01747","article-title":"Effects of glucagon-like peptide-1 and exendins on kinase activity, glucose transport and lipid metabolism in adipocytes from normal and type-2 diabetic rats","volume":"35","author":"Sancho","year":"2005","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.phrs.2026.108278_bib112","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1095753","article-title":"Effect of dual glucose-dependent insulinotropic peptide\/glucagon-like peptide-1 receptor agonist on weight loss in subjects with obesity","volume":"14","author":"Zaffina","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"10.1016\/j.phrs.2026.108278_bib113","doi-asserted-by":"crossref","DOI":"10.37349\/eemd.2025.101452","article-title":"Effects of GLP-1 receptor agonists and dual incretin agonists on adipocyte type and size","volume":"2","author":"Turashvili","year":"2025","journal-title":"Explor. Endocr. Metab. Dis."},{"issue":"7","key":"10.1016\/j.phrs.2026.108278_bib114","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.cmet.2024.05.010","article-title":"Tirzepatide modulates the regulation of adipocyte nutrient metabolism through long-acting activation of the GIP receptor","volume":"36","author":"Regmi","year":"2024","journal-title":"Cell. Metab."},{"key":"10.1016\/j.phrs.2026.108278_bib115","article-title":"The influence of Glucose-dependent Insulinotropic Polypeptide (GIP) on human adipose tissue and fat metabolism: Implications for obesity, type 2 diabetes and Non-Alcoholic Fatty Liver Disease (NAFLD)","volume":"125","author":"Thondam","year":"2020","journal-title":"Pept. (N. Y. )."},{"issue":"3","key":"10.1016\/j.phrs.2026.108278_bib116","doi-asserted-by":"crossref","DOI":"10.1530\/JOE-23-0361","article-title":"The interplay of glucose-dependent insulinotropic polypeptide in adipose tissue","volume":"261","author":"Kagdi","year":"2024","journal-title":"J. Endocrinol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108278_bib117","doi-asserted-by":"crossref","first-page":"6274","DOI":"10.1038\/s41598-019-42770-1","article-title":"Role of adipose tissue GLP-1R expression in metabolic improvement after bariatric surgery in patients with type 2 diabetes","volume":"9","author":"Ejarque","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.phrs.2026.108278_bib118","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12933-022-01604-7","article-title":"Tirzepatide, a dual GIP\/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction","volume":"21","author":"Nauck","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"issue":"6","key":"10.1016\/j.phrs.2026.108278_bib119","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/s42255-023-00811-0","article-title":"The incretin co-agonist tirzepatide requires GIPR for hormone secretion from human islets","volume":"5","author":"El","year":"2023","journal-title":"Nat. Metab."},{"key":"10.1016\/j.phrs.2026.108278_bib120","doi-asserted-by":"crossref","unstructured":"M.A. Sheridan and S.A. Sower, \u201cA Tribute to Erika M. Plisetskaya: New Insights on the Function and Evolution of Gastroenteropancreatic Hormones. Introduction to the Symposium1,\u201d https:\/\/doi.org\/10.1668\/0003-1569(2000)040[0161:ATTEMP]2.0.CO;2, vol. 40, no. 2, pp. 161\u2013164, Apr. 2000, doi: 10.1668\/0003-1569(2000)040.","DOI":"10.1668\/0003-1569(2000)040[0161:ATTEMP]2.0.CO;2"},{"issue":"4","key":"10.1016\/j.phrs.2026.108278_bib121","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","article-title":"Mechanisms of Insulin Action and Insulin Resistance","volume":"98","author":"Petersen","year":"2018","journal-title":"Physiol. Rev."},{"issue":"6","key":"10.1016\/j.phrs.2026.108278_bib122","first-page":"2134","article-title":"Impaired adipocyte glucose transport regulators in morbid obesity - Possible mechanisms contributing to metabolic dysfunction","volume":"26","author":"Mourelatou","year":"2022","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"38","key":"10.1016\/j.phrs.2026.108278_bib123","doi-asserted-by":"crossref","first-page":"27982","DOI":"10.1074\/jbc.M602873200","article-title":"Insulin-stimulated Interaction between Insulin Receptor Substrate 1 and p85\u03b1 and Activation of Protein Kinase B\/Akt Require Rab5","volume":"281","author":"Su","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2026.108278_bib124","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cmet.2006.12.006","article-title":"Gapex-5, a Rab31 Guanine Nucleotide Exchange Factor that Regulates Glut4 Trafficking in Adipocytes","volume":"5","author":"Lodhi","year":"2007","journal-title":"Cell. Metab."},{"issue":"2","key":"10.1016\/j.phrs.2026.108278_bib125","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ecl.2004.03.002","article-title":"The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals","volume":"33","author":"Reaven","year":"2004","journal-title":"Endocrinol. Metab. Clin. North. Am."},{"issue":"7049","key":"10.1016\/j.phrs.2026.108278_bib126","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature03711","article-title":"Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes","volume":"436","author":"Yang","year":"2005","journal-title":"Nature"},{"issue":"7121","key":"10.1016\/j.phrs.2026.108278_bib127","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/nature05482","article-title":"Mechanisms linking obesity to insulin resistance and type 2 diabetes","volume":"444","author":"Kahn","year":"2006","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.phrs.2026.108278_bib128","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1172\/JCI117252","article-title":"Mechanisms of fatty acid-induced inhibition of glucose uptake","volume":"93","author":"Boden","year":"1994","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.phrs.2026.108278_bib129","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1172\/JCI10583","article-title":"Cellular mechanisms of insulin resistance","volume":"106","author":"Shulman","year":"2000","journal-title":"J. Clin. Investig."},{"issue":"44","key":"10.1016\/j.phrs.2026.108278_bib130","doi-asserted-by":"crossref","first-page":"45304","DOI":"10.1074\/jbc.C400186200","article-title":"Protein Kinase C \u03b8 Inhibits Insulin Signaling by Phosphorylating IRS1 at Ser1101","volume":"279","author":"Li","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2026.108278_bib131","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2023.110691","article-title":"Association between obesity, inflammation and insulin resistance: Insights into signaling pathways and therapeutic interventions","volume":"200","author":"Suren Garg","year":"2023","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"1","key":"10.1016\/j.phrs.2026.108278_bib132","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1186\/s40001-023-01424-9","article-title":"Crosstalk between autophagy and insulin resistance: evidence from different tissues","volume":"28","author":"Sadeghi","year":"2023","journal-title":"Eur. J. Med. Res."},{"issue":"2","key":"10.1016\/j.phrs.2026.108278_bib133","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.molmet.2016.12.001","article-title":"JNK at the crossroad of obesity, insulin resistance, and cell stress response","volume":"6","author":"Solinas","year":"2017","journal-title":"Mol. Metab."},{"issue":"S1","key":"10.1016\/j.phrs.2026.108278_bib134","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1038\/ijosup.2012.3","article-title":"Metabolic heterogeneity of obesity: role of adipose tissue","volume":"2","author":"McLaughlin","year":"2012","journal-title":"Int. J. Obes. Suppl."},{"issue":"9733","key":"10.1016\/j.phrs.2026.108278_bib135","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/S0140-6736(10)60408-4","article-title":"Lipid-induced insulin resistance: unravelling the mechanism","volume":"375","author":"Samuel","year":"2010","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.phrs.2026.108278_bib136","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s00125-007-0708-y","article-title":"Enhanced proportion of small adipose cells in insulin-resistant vs insulin-sensitive obese individuals implicates impaired adipogenesis","volume":"50","author":"McLaughlin","year":"2007","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.phrs.2026.108278_bib137","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1172\/JCI25102","article-title":"Inflammation, stress, and diabetes","volume":"115","author":"Wellen","year":"2005","journal-title":"J. Clin. Investig."},{"issue":"7","key":"10.1016\/j.phrs.2026.108278_bib138","first-page":"856","article-title":"The Interplay between Obesity and Inflammation","volume":"14","author":"Savulescu-Fiedler","year":"2024"},{"issue":"2","key":"10.1016\/j.phrs.2026.108278_bib139","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1210\/clinem\/dgaa863","article-title":"Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes","volume":"106","author":"Thomas","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.phrs.2026.108278_bib140","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1210\/clinem\/dgae319","article-title":"Effects of Tirzepatide vs Semaglutide on \u03b2-Cell Function, Insulin Sensitivity, and Glucose Control During a Meal Test","volume":"109","author":"Mather","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.phrs.2026.108278_bib141","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12020-007-9011-4","article-title":"GLP-1 amplifies insulin signaling by up-regulation of IR\u03b2, IRS-1 and Glut4 in 3T3-L1 adipocytes","volume":"32","author":"Gao","year":"2007","journal-title":"Endocrine"},{"issue":"5","key":"10.1016\/j.phrs.2026.108278_bib142","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0006-2952(01)00924-8","article-title":"Exendin-4 increases insulin sensitivity via a PI-3-kinase-dependent mechanism: contrasting effects of GLP-1","volume":"63","author":"Idris","year":"2002","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108278_bib143","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1134\/S000629792103010X","article-title":"Direct Effect of the Synthetic Analogue of Glucagon-Like Peptide Type 1, Liraglutide, on Mature Adipocytes Is Realized through Adenylate-Cyclase-Dependent Enhancing of Insulin Sensitivity","volume":"86","author":"Mamontova","year":"2021","journal-title":"Biochemistry (Moscow)"},{"key":"10.1016\/j.phrs.2026.108278_bib144","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172594","article-title":"Liraglutide improves insulin sensitivity in high fat diet induced diabetic mice through multiple pathways","volume":"861","author":"Zhou","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2026.108278_bib145","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.01168","article-title":"GLP-1 Improves Adipocyte Insulin Sensitivity Following Induction of Endoplasmic Reticulum Stress","volume":"9","author":"Jiang","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.phrs.2026.108278_bib146","doi-asserted-by":"crossref","first-page":"692","DOI":"10.3109\/10715762.2011.567985","article-title":"ER stress inducer, thapsigargin, decreases extracellular-superoxide dismutase through MEK\/ERK signalling cascades in COS7 cells","volume":"45","author":"Kamiya","year":"2011","journal-title":"Free. Radic. Res."},{"key":"10.1016\/j.phrs.2026.108278_bib147","doi-asserted-by":"crossref","unstructured":"I. Tanida, T. Ueno, and E. Kominami, \u201cLC3 and Autophagy,\u201d 2008, pp. 77\u201388. doi: 10.1007\/978-1-59745-157-4_4.","DOI":"10.1007\/978-1-59745-157-4_4"},{"issue":"12","key":"10.1016\/j.phrs.2026.108278_bib148","doi-asserted-by":"crossref","DOI":"10.1172\/JCI146353","article-title":"GIPR agonism mediates weight-independent insulin sensitization by tirzepatide in obese mice","volume":"131","author":"Samms","year":"2021","journal-title":"J. Clin. Investig."},{"issue":"S3","key":"10.1016\/j.phrs.2026.108278_bib149","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/dom.14496","article-title":"\u201cThe evolving story of incretins ( <scp>GIP<\/scp> and <scp>GLP<\/scp> -1) in metabolic and cardiovascular disease: A pathophysiological update,\u201d","volume":"23","author":"Nauck","year":"2021","journal-title":"Diabetes Obes. Metab."},{"issue":"1","key":"10.1016\/j.phrs.2026.108278_bib150","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000113935","article-title":"Polygenic Obesity in Humans","volume":"1","author":"Hinney","year":"2008","journal-title":"Obes. Facts"},{"issue":"10","key":"10.1016\/j.phrs.2026.108278_bib151","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3390\/cimb47100787","article-title":"Obesity as a Multifactorial Chronic Disease: Molecular Mechanisms, Systemic Impact, and Emerging Digital Interventions","volume":"47","author":"M\u0142ynarska","year":"2025","journal-title":"Curr. Issues Mol. Biol."},{"issue":"4","key":"10.1016\/j.phrs.2026.108278_bib152","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF01221856","article-title":"The influence of genetic background on the expression of the obese (ob) gene in the mouse","volume":"9","author":"Coleman","year":"1973","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.phrs.2026.108278_bib153","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0026-0495(77)90128-7","article-title":"Laboratory animals exhibiting obesity and diabetes syndromes","volume":"26","author":"Herberg","year":"1977","journal-title":"Metabolism"},{"issue":"12","key":"10.1016\/j.phrs.2026.108278_bib154","doi-asserted-by":"crossref","first-page":"10309","DOI":"10.3390\/ijms241210309","article-title":"Experimental Models to Study Diabetes Mellitus and Its Complications: Limitations and New Opportunities","volume":"24","author":"Mart\u00edn-Carro","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.phrs.2026.108278_bib155","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/sj.ijo.0800636","article-title":"Effect of the antiobesity agent sibutramine in obese-diabetic ob\/ob mice","volume":"22","author":"Day","year":"1998","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.phrs.2026.108278_bib156","doi-asserted-by":"crossref","unstructured":"C.-Y. Wang and J.K. Liao, \u201cA Mouse Model of Diet-Induced Obesity and Insulin Resistance,\u201d 2012, pp. 421\u2013433. doi: 10.1007\/978-1-61779-430-8_27.","DOI":"10.1007\/978-1-61779-430-8_27"},{"issue":"1","key":"10.1016\/j.phrs.2026.108278_bib157","doi-asserted-by":"crossref","first-page":"19556","DOI":"10.1038\/s41598-019-55987-x","article-title":"Effects of different diets used in diet-induced obesity models on insulin resistance and vascular dysfunction in C57BL\/6 mice","volume":"9","author":"Lang","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.phrs.2026.108278_bib158","doi-asserted-by":"crossref","DOI":"10.4103\/ijpvm.IJPVM_193_20","article-title":"Adiponectin: Role in Physiology and Pathophysiology","volume":"11","author":"Nguyen","year":"2020","journal-title":"Int. J. Prev. Med."},{"issue":"5","key":"10.1016\/j.phrs.2026.108278_bib159","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.3390\/biomedicines11051290","article-title":"The Role of Adipokines in Health and Disease","volume":"11","author":"Clemente-Su\u00e1rez","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.phrs.2026.108278_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.diff.2024.100832","article-title":"Deciphering endocrine function of adipose tissue and its significant influences in obesity-related diseases caused by its dysfunction","volume":"141","author":"Duan","year":"2025","journal-title":"Differentiation"},{"issue":"4","key":"10.1016\/j.phrs.2026.108278_bib161","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3390\/physiologia5040050","article-title":"Beyond Calories: Redox Interactions in Adipose Tissue That Lead to Metabolic Pathologies","volume":"5","author":"Miranda-Mart\u00ednez","year":"2025","journal-title":"Physiologia"},{"issue":"11","key":"10.1016\/j.phrs.2026.108278_bib162","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.388","article-title":"Adiponectin reduces ER stress-induced apoptosis through PPAR\u03b1 transcriptional regulation of ATF2 in mouse adipose","volume":"7","author":"Liu","year":"2016","journal-title":"Cell. Death Dis."},{"issue":"5","key":"10.1016\/j.phrs.2026.108278_bib163","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.cmet.2016.04.011","article-title":"Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk","volume":"23","author":"Stern","year":"2016","journal-title":"Cell. Metab."},{"issue":"10","key":"10.1016\/j.phrs.2026.108278_bib164","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1161\/STROKEAHA.107.485540","article-title":"Leptin:Adiponectin Ratio Is an Independent Predictor of Intima Media Thickness of the Common Carotid Artery","volume":"38","author":"Norata","year":"2007","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.phrs.2026.108278_bib165","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.1038\/s41598-017-06997-0","article-title":"Involvement of the leptin-adiponectin axis in inflammation and oxidative stress in the metabolic syndrome","volume":"7","author":"Fr\u00fchbeck","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2026.108278_bib166","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cca.2013.02.003","article-title":"Adipokines in obesity","volume":"419","author":"de","year":"2013","journal-title":"Clin. Chim. Acta"},{"issue":"5","key":"10.1016\/j.phrs.2026.108278_bib167","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191593","article-title":"The pleiotropic roles of leptin in metabolism, immunity, and cancer","volume":"218","author":"de Candia","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.phrs.2026.108278_bib168","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.domaniend.2017.06.001","article-title":"Adipose triglyceride lipase protein abundance and translocation to the lipid droplet increase during leptin-induced lipolysis in bovine adipocytes","volume":"61","author":"Koltes","year":"2017","journal-title":"Domest. Anim. Endocrinol."},{"key":"10.1016\/j.phrs.2026.108278_bib169","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2019.00841","article-title":"Leptin Induces Proadipogenic and Proinflammatory Signaling in Adipocytes","volume":"10","author":"Palhinha","year":"2019","journal-title":"Front. Endocrinol. (Lausanne)."},{"issue":"6818","key":"10.1016\/j.phrs.2026.108278_bib170","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35053000","article-title":"The hormone resistin links obesity to diabetes","volume":"409","author":"Steppan","year":"2001","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.phrs.2026.108278_bib171","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.bbrc.2003.09.093","article-title":"Comparative studies of resistin expression and phylogenomics in human and mouse","volume":"310","author":"Yang","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2026.108278_bib172","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.bbrc.2020.11.013","article-title":"Resistin is co-secreted with adiponectin in white mouse adipocytes","volume":"534","author":"Musovic","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.phrs.2026.108278_bib173","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.clim.2009.07.013","article-title":"The role of resistin as a regulator of inflammation: Implications for various human pathologies","volume":"133","author":"Filkov\u00e1","year":"2009","journal-title":"Clin. Immunol."},{"issue":"15","key":"10.1016\/j.phrs.2026.108278_bib174","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1111\/febs.15322","article-title":"Resistin in metabolism, inflammation, and disease","volume":"287","author":"Tripathi","year":"2020","journal-title":"FEBS J."},{"issue":"4","key":"10.1016\/j.phrs.2026.108278_bib175","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.bbrc.2005.06.202","article-title":"Human resistin stimulates the pro-inflammatory cytokines TNF-\u03b1 and IL-12 in macrophages by NF-\u03baB-dependent pathway","volume":"334","author":"Silswal","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.phrs.2026.108278_bib176","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000031","article-title":"Human Resistin Is a Systemic Immune-Derived Proinflammatory Cytokine Targeting both Leukocytes and Adipocytes","volume":"1","author":"Nagaev","year":"2006","journal-title":"PLoS. One"},{"issue":"2","key":"10.1016\/j.phrs.2026.108278_bib177","first-page":"1431","article-title":"Cloning and Characterization of the cDNA Encoding a Novel Human pre-B-Cell Colony-enhancing Factor","volume":"14","author":"Samal","year":"1994","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.phrs.2026.108278_bib178","article-title":"Asprosin, visfatin and subfatin as new biomarkers of obesity and metabolic syndrome","author":"Ugur K","year":"2022","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.phrs.2026.108278_bib179","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1080\/13813455.2025.2486290","article-title":"Serum levels of omentin and visfatin in patients with metabolic syndrome","volume":"131","author":"Sherly A","year":"2025","journal-title":"Arch. Physiol. Biochem."},{"issue":"4","key":"10.1016\/j.phrs.2026.108278_bib180","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/s00125-006-0173-z","article-title":"Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin","volume":"49","author":"Curat","year":"2006","journal-title":"Diabetologia"},{"issue":"8","key":"10.1016\/j.phrs.2026.108278_bib181","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41366-023-01317-1","article-title":"Visceral mesenchymal stem cells from type 2 diabetes donors activate triglycerides synthesis in healthy adipocytes via metabolites exchange and cytokines secretion","volume":"47","author":"Stafeev","year":"2023","journal-title":"Int. J. Obes."},{"issue":"1","key":"10.1016\/j.phrs.2026.108278_bib182","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.immuni.2021.12.013","article-title":"Inflammation in obesity, diabetes, and related disorders","volume":"55","author":"Rohm","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.phrs.2026.108278_bib183","article-title":"Adipose tissue-derived mediators of systemic inflammation and metabolic control","volume":"37","author":"Alexaki","year":"2024","journal-title":"Curr. Opin. Endocr. Metab. Res."},{"issue":"10","key":"10.1016\/j.phrs.2026.108278_bib184","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1089\/met.2015.0095","article-title":"Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic Strategies","volume":"13","author":"Manna","year":"2015","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"10.1016\/j.phrs.2026.108278_bib185","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2019.01638","article-title":"The Impact of Oxidative Stress on Adipose Tissue Energy Balance","volume":"10","author":"Masschelin","year":"2020","journal-title":"Front. Physiol."},{"issue":"16","key":"10.1016\/j.phrs.2026.108278_bib186","doi-asserted-by":"crossref","first-page":"10601","DOI":"10.1074\/jbc.M808742200","article-title":"Reactive Oxygen Species Facilitate Adipocyte Differentiation by Accelerating Mitotic Clonal Expansion","volume":"284","author":"Lee","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.phrs.2026.108278_bib187","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1089\/scd.2012.0306","article-title":"Differentiation of Human Adipose-Derived Stem Cells into Fat Involves Reactive Oxygen Species and Forkhead Box O1 Mediated Upregulation of Antioxidant Enzymes","volume":"22","author":"Higuchi","year":"2013","journal-title":"Stem Cells Dev."},{"issue":"12","key":"10.1016\/j.phrs.2026.108278_bib188","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1172\/JCI21625","article-title":"Increased oxidative stress in obesity and its impact on metabolic syndrome","volume":"114","author":"Furukawa","year":"2004","journal-title":"J. Clin. Investig."},{"issue":"17","key":"10.1016\/j.phrs.2026.108278_bib189","doi-asserted-by":"crossref","first-page":"8544","DOI":"10.3390\/ijms26178544","article-title":"The Interplay Between Oxidative Stress and Lipid Composition in Obesity-Induced Inflammation: Antioxidants as Therapeutic Agents in Metabolic Diseases","volume":"26","author":"Olivares-Vicente","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.phrs.2026.108278_bib190","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/cbf.3751","article-title":"Semaglutide (GLP-1 receptor agonist) stimulates browning on subcutaneous fat adipocytes and mitigates inflammation and endoplasmic reticulum stress in visceral fat adipocytes of obese mice","volume":"40","author":"Martins","year":"2022","journal-title":"Cell. Biochem. Funct."},{"key":"10.1016\/j.phrs.2026.108278_bib191","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113499","article-title":"Tirzepatide\u2019s role in targeting adipose tissue macrophages to reduce obesity-related inflammation and improve insulin resistance","volume":"143","author":"Xia","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"09","key":"10.1016\/j.phrs.2026.108278_bib192","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1055\/s-0033-1343472","article-title":"Glucagon-like Peptide-1 Upregulates Visfatin Expression in 3T3-L1 Adipocytes","volume":"45","author":"Liu","year":"2013","journal-title":"Horm. Metab. Res."},{"issue":"3","key":"10.1016\/j.phrs.2026.108278_bib193","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.bbrc.2009.10.015","article-title":"Exendin-4, a GLP-1 receptor agonist, directly induces adiponectin expression through protein kinase A pathway and prevents inflammatory adipokine expression","volume":"390","author":"Kim Chung","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2026.108278_bib194","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.mce.2014.12.021","article-title":"Effect of liraglutide on proliferation and differentiation of human adipose stem cells","volume":"402","author":"Cantini","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.phrs.2026.108278_bib195","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1379189","article-title":"Anti-inflammatory effect of semaglutide: updated systematic review and meta-analysis","volume":"11","author":"Masson","year":"2024","journal-title":"Front. Cardiovasc. Med."},{"issue":"7","key":"10.1016\/j.phrs.2026.108278_bib196","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1111\/dom.16366","article-title":"\u201cThe effect of <scp>GLP<\/scp> -1 receptor agonists on circulating inflammatory markers in type 2 diabetes patients: A systematic review and meta-analysis,\u201d","volume":"27","author":"Ren","year":"2025","journal-title":"Diabetes Obes. Metab."},{"issue":"1","key":"10.1016\/j.phrs.2026.108278_bib197","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12933-022-01585-7","article-title":"Impact of semaglutide on high-sensitivity C-reactive protein: exploratory patient-level analyses of SUSTAIN and PIONEER randomized clinical trials","volume":"21","author":"Mosenzon","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.phrs.2026.108278_bib198","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.molmet.2019.08.006","article-title":"Physiological roles of the GIP receptor in murine brown adipose tissue","volume":"28","author":"Beaudry","year":"2019","journal-title":"Mol. Metab."},{"issue":"8","key":"10.1016\/j.phrs.2026.108278_bib199","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s00125-015-3618-4","article-title":"GIP increases adipose tissue expression and blood levels of MCP-1 in humans and links high energy diets to inflammation: a randomised trial","volume":"58","author":"G\u00f6gebakan","year":"2015","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.phrs.2026.108278_bib200","doi-asserted-by":"crossref","first-page":"E414","DOI":"10.1152\/ajpendo.00418.2014","article-title":"Increased GIP signaling induces adipose inflammation via a HIF-1\u03b1-dependent pathway and impairs insulin sensitivity in mice","volume":"308","author":"Chen","year":"2015","journal-title":"Am. J. Physiol. -Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.phrs.2026.108278_bib201","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41591-024-03374-z","article-title":"Effects of tirzepatide on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial","volume":"31","author":"Borlaug","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2026.108278_bib202","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.83712","article-title":"Effects of Tirzepatide on Patients With Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Retrospective Cohort Study","author":"Okuma","year":"2025","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.phrs.2026.108278_bib203","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/dom.14553","article-title":"\u201cThe dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist tirzepatide improves cardiovascular risk biomarkers in patients with type 2 diabetes: A p <scp>ost hoc<\/scp> analysis,\u201d","volume":"24","author":"Wilson","year":"2022","journal-title":"Diabetes Obes. Metab."},{"issue":"9","key":"10.1016\/j.phrs.2026.108278_bib204","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1056\/NEJMoa2504214","article-title":"Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity \u2014 A Phase 2 Trial","volume":"393","author":"Jastreboff","year":"2025","journal-title":"New. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.phrs.2026.108278_bib205","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.3390\/cells10113030","article-title":"Human Brown Adipose Tissue and Metabolic Health: Potential for Therapeutic Avenues","volume":"10","author":"Singh","year":"2021","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.phrs.2026.108278_bib206","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/nm.3361","article-title":"Brown and beige fat: development, function and therapeutic potential","volume":"19","author":"Harms","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2026.108278_bib207","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1152\/ajpcell.00010.2011","article-title":"Triiodothyronine induces UCP-1 expression and mitochondrial biogenesis in human adipocytes","volume":"302","author":"Lee","year":"2012","journal-title":"Am. J. Physiol. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108278_bib208","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cmet.2014.12.009","article-title":"Activation of human brown adipose tissue by a \u03b23-adrenergic receptor agonist","volume":"21","author":"Cypess","year":"2015","journal-title":"Cell. Metab."},{"key":"10.1016\/j.phrs.2026.108278_bib209","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109537","article-title":"Liraglutide improves vascular dysfunction by regulating a cAMP-independent PKA-AMPK pathway in perivascular adipose tissue in obese mice","volume":"120","author":"Han","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.phrs.2026.108278_bib210","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s12020-018-1826-7","article-title":"Liraglutide induces beige fat development and promotes mitochondrial function in diet induced obesity mice partially through AMPK-SIRT-1-PGC1-\u03b1 cell signaling pathway","volume":"64","author":"Zhou","year":"2019","journal-title":"Endocrine"},{"key":"10.1016\/j.phrs.2026.108278_bib211","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.803363","article-title":"Liraglutide Activates Type 2 Deiodinase and Enhances \u03b23-Adrenergic-Induced Thermogenesis in Mouse Adipose Tissue","volume":"12","author":"Oliveira","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"10.1016\/j.phrs.2026.108278_bib212","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2024.112225","article-title":"Liraglutide promotes UCP1 expression and lipolysis of adipocytes by promoting the secretion of irisin from skeletal muscle cells","volume":"588","author":"Zhang","year":"2024","journal-title":"Mol. Cell. Endocrinol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108278_bib213","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4103\/cjp.cjp_87_21","article-title":"Combined Effects of Voluntary Running and Liraglutide on Glucose Homeostasis, Fatty Acid Composition of Brown Adipose Tissue Phospholipids, and White Adipose Tissue Browning in Db\/Db Mice","volume":"65","author":"Yin","year":"2022","journal-title":"Chin. J. Physiol."},{"issue":"6","key":"10.1016\/j.phrs.2026.108278_bib214","article-title":"Glucagon-like peptide-1 receptor agonist regulates fat browning by altering the gut microbiota and ceramide metabolism","volume":"4","author":"Lin","year":"2023","journal-title":"MedComm (Beijing)"},{"issue":"11","key":"10.1016\/j.phrs.2026.108278_bib215","article-title":"Anti-diabetic effects of GLP1 analogs are mediated by thermogenic interleukin-6 signaling in adipocytes","volume":"3","author":"Gutierrez","year":"2022","journal-title":"Cell. Rep. Med."},{"issue":"5","key":"10.1016\/j.phrs.2026.108278_bib216","doi-asserted-by":"crossref","DOI":"10.1096\/fj.201903253R","article-title":"Glucose-dependent insulinotropic polypeptide modifies adipose plasticity and promotes beige adipogenesis of human omental adipose-derived stem cells","volume":"35","author":"Chen","year":"2021","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2026.108278_bib217","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.178133","article-title":"Activation of cyclooxygenase-2 signaling mediates liraglutide-induced adipose lipolytic activity","volume":"1006","author":"Li","year":"2025","journal-title":"Eur. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.phrs.2026.108278_bib218","doi-asserted-by":"crossref","DOI":"10.1177\/03000605211055059","article-title":"Liraglutide suppresses obesity and promotes browning of white fat via miR-27b in vivo and in vitro","volume":"49","author":"Wang","year":"2021","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.phrs.2026.108278_bib219","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.bbrc.2023.04.012","article-title":"GLP-1 receptor agonist, liraglutide, protects podocytes from apoptosis in diabetic nephropathy by promoting white fat browning","volume":"664","author":"Wang","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2026.108278_bib220","article-title":"GLP-1 Induces the Expression of FNDC5 Derivatives That Execute Lipolytic Actions","volume":"9","author":"Li","year":"2021","journal-title":"Front. Cell. Dev. Biol."},{"issue":"5","key":"10.1016\/j.phrs.2026.108278_bib221","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s00125-016-3896-5","article-title":"GLP-1 receptor agonist promotes brown remodelling in mouse white adipose tissue through SIRT1","volume":"59","author":"Xu","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.phrs.2026.108278_bib222","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2023.110635","article-title":"Liraglutide demonstrates a therapeutic effect on mitochondrial dysfunction in human SGBS adipocytes in vitro","volume":"199","author":"Vaittinen","year":"2023","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"5","key":"10.1016\/j.phrs.2026.108278_bib223","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1111\/dom.16294","article-title":"Tirzepatide reduces body weight by increasing fat utilization via the central nervous system-adipose tissue axis in male mice","volume":"27","author":"Zhang","year":"2025","journal-title":"Diabetes Obes. Metab."},{"issue":"1","key":"10.1016\/j.phrs.2026.108278_bib224","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1749-6632.2008.03627.x","article-title":"Feeding Behavior in Mammals Including Humans","volume":"1163","author":"Magni","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.phrs.2026.108278_bib225","doi-asserted-by":"crossref","unstructured":"G.J. Morton, D.E. Cummings, D.G. Baskin, G.S. Barsh, and M.W. Schwartz, \u201cCentral nervous system control of food intake and body weight,\u201d Sep. 21, 2006, Nature Publishing Group. doi: 10.1038\/nature05026.","DOI":"10.1038\/nature05026"},{"issue":"3","key":"10.1016\/j.phrs.2026.108278_bib226","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41573-021-00337-8","article-title":"Anti-obesity drug discovery: advances and challenges","volume":"21","author":"M\u00fcller","year":"2022","journal-title":"Nat. Rev. Drug. Discov."},{"issue":"2","key":"10.1016\/j.phrs.2026.108278_bib227","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1530\/eje.1.02220","article-title":"Is ghrelin a signal of decreased fat-free mass in elderly subjects?","volume":"155","author":"Bertoli","year":"2006","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.phrs.2026.108278_bib228","doi-asserted-by":"crossref","DOI":"10.1016\/j.slasd.2025.100218","article-title":"Optimized scaffold-free human 3D adipose tissue organoid culture for obesity and disease modeling","volume":"31","author":"Dariolli","year":"2025","journal-title":"SLAS Discov."},{"issue":"1","key":"10.1016\/j.phrs.2026.108278_bib229","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40246-022-00388-x","article-title":"Integrative analysis of multi-omics data to detect the underlying molecular mechanisms for obesity in vivo in humans","volume":"16","author":"Zhang","year":"2022","journal-title":"Hum. Genom."},{"issue":"12","key":"10.1016\/j.phrs.2026.108278_bib230","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.molmed.2023.09.004","article-title":"Multiomics tools for improved atherosclerotic cardiovascular disease management","volume":"29","author":"Sopic","year":"2023","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.phrs.2026.108278_bib231","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2025.120414","article-title":"Multiomics in atherosclerotic cardiovascular disease","volume":"408","author":"Nordestgaard","year":"2025","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.phrs.2026.108278_bib232","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41467-025-56013-7","article-title":"Multi-omics architecture of childhood obesity and metabolic dysfunction uncovers biological pathways and prenatal determinants","volume":"16","author":"Stratakis","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.phrs.2026.108278_bib233","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11883-025-01380-1","article-title":"Toward Precision Medicine in Atherosclerotic Cardiovascular Disease: Insights from Omics Data into Sex Differences","volume":"28","author":"Munjas","year":"2025","journal-title":"Curr. Atheroscler. Rep."},{"issue":"5","key":"10.1016\/j.phrs.2026.108278_bib234","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1111\/dom.16275","article-title":"Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight","volume":"27","author":"Look","year":"2025","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.phrs.2026.108278_bib235","doi-asserted-by":"crossref","unstructured":"G. Rossi, L. Bucciarelli, C.L. Mananguite, M. Giovarelli, and P. Fiorina, \u201cMuscle loss and GLP-1R agonists use,\u201d 2025, Springer-Verlag Italia s.r.l. doi: 10.1007\/s00592-025-02611-2.","DOI":"10.1007\/s00592-025-02611-2"},{"issue":"6628","key":"10.1016\/j.phrs.2026.108278_bib236","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/387083a0","article-title":"Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member","volume":"387","author":"McPherron","year":"1997","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.phrs.2026.108278_bib237","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.33457","article-title":"Effect of Bimagrumab vs Placebo on Body Fat Mass Among Adults With Type 2 Diabetes and Obesity","volume":"4","author":"Heymsfield","year":"2021","journal-title":"JAMA Netw. Open."},{"issue":"5","key":"10.1016\/j.phrs.2026.108278_bib238","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1194\/jlr.P025536","article-title":"Evidence for regulated monoacylglycerol acyltransferase expression and activity in human liver","volume":"53","author":"Hall","year":"2012","journal-title":"J. Lipid Res."},{"issue":"11","key":"10.1016\/j.phrs.2026.108278_bib239","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.cmet.2022.10.007","article-title":"MGAT2 inhibitor decreases liver fibrosis and inflammation in murine NASH models and reduces body weight in human adults with obesity","volume":"34","author":"Cheng","year":"2022","journal-title":"Cell. Metab."},{"key":"10.1016\/j.phrs.2026.108278_bib240","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.molmet.2017.11.009","article-title":"Amylin \u2013 Its role in the homeostatic and hedonic control of eating and recent developments of amylin analogs to treat obesity","volume":"8","author":"Boyle","year":"2018","journal-title":"Mol. Metab."},{"issue":"10317","key":"10.1016\/j.phrs.2026.108278_bib241","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/S0140-6736(21)01751-7","article-title":"Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial","volume":"398","author":"Lau","year":"2021","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.phrs.2026.108278_bib242","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJMoa2502081","article-title":"Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity","volume":"393","author":"Garvey","year":"2025","journal-title":"New. Engl. J. Med."},{"issue":"778","key":"10.1016\/j.phrs.2026.108278_bib243","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adp5765","article-title":"The pharmacological basis for nonpeptide agonism of the GLP-1 receptor by orforglipron","volume":"16","author":"Sloop","year":"2024","journal-title":"Sci. Transl. Med."},{"issue":"467","key":"10.1016\/j.phrs.2026.108278_bib244","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar7047","article-title":"Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist","volume":"10","author":"Buckley","year":"2018","journal-title":"Sci. Transl. Med."},{"issue":"18","key":"10.1016\/j.phrs.2026.108278_bib245","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1056\/NEJMoa2511774","article-title":"Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment","volume":"393","author":"Wharton","year":"2025","journal-title":"New. Engl. J. Med."},{"issue":"10534","key":"10.1016\/j.phrs.2026.108278_bib246","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(26)00202-3","article-title":"Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3): a multinational, multicentre, non-inferiority, open-label, randomised, phase 3 trial","volume":"407","author":"Rosenstock","year":"2026","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.phrs.2026.108278_bib247","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0021-9258(18)96968-1","article-title":"Metabolism of isolated fat cells. 3. The similar inhibitory action of phospholipase C (Clostridium perfringens alpha toxin) and of insulin on lipolysis stimulated by lipolytic hormones and theophylline","volume":"241","author":"Rodbell","year":"1966","journal-title":"J. Biol. Chem."},{"issue":"04","key":"10.1016\/j.phrs.2026.108278_bib248","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1055\/s-0028-1093959","article-title":"Effects of Denervation on the Metabolism and the Response to Glucagon of White Adipose Tissue of Rats","volume":"5","author":"Lefebvre","year":"1973","journal-title":"Horm. Metab. Res."},{"issue":"9","key":"10.1016\/j.phrs.2026.108278_bib249","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0022-2275(20)41151-4","article-title":"Hormonal regulation of hormone-sensitive lipase activity and mRNA levels in isolated rat adipocytes","volume":"35","author":"Slavin","year":"1994","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.phrs.2026.108278_bib250","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0305-0491(71)90254-9","article-title":"Effects of glucagon, epinephrine and insulin on in vitro lipolysis of adipose tissue from mammals and birds","volume":"39","author":"Prigge","year":"1971","journal-title":"Comparative Biochemistry Physiology Part B Comparative Biochemistry"},{"issue":"13","key":"10.1016\/j.phrs.2026.108278_bib251","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.3390\/ijms20133314","article-title":"Glucagon Receptor Signaling and Glucagon Resistance","volume":"20","author":"Janah","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.phrs.2026.108278_bib252","doi-asserted-by":"crossref","first-page":"E1560","DOI":"10.1152\/ajpendo.00504.2011","article-title":"Glucagon regulates ACC activity in adipocytes through the CAMKK\u03b2\/AMPK pathway","volume":"302","author":"Peng","year":"2012","journal-title":"Am. J. Physiol. -Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.phrs.2026.108278_bib253","doi-asserted-by":"crossref","first-page":"E389","DOI":"10.1152\/ajpendo.00078.2022","article-title":"Glucagon receptor signaling at white adipose tissue does not regulate lipolysis","volume":"323","author":"Vasileva","year":"2022","journal-title":"Am. J. Physiol. -Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.phrs.2026.108278_bib254","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0196-9781(89)90039-9","article-title":"Human glucagon and vasoactive intestinal polypeptide (VIP) stimulate free fatty acid release from human adipose tissue in vitro","volume":"10","author":"Richter","year":"1989","journal-title":"Pept. (N. Y. )."},{"issue":"08","key":"10.1016\/j.phrs.2026.108278_bib255","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1055\/s-2007-979981","article-title":"Physiological Effect of Glucagon in Human Isolated Adipocytes","volume":"27","author":"Perea","year":"1995","journal-title":"Horm. Metab. Res."},{"issue":"3","key":"10.1016\/j.phrs.2026.108278_bib256","first-page":"1229","article-title":"Action of Glucagon and Glucagon-Like Peptide-1-(7-36) Amide on Lipolysis in Human Subcutaneous Adipose Tissue and Skeletal Muscle in Vivo 1","volume":"86","author":"Bertin","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.phrs.2026.108278_bib257","first-page":"2085","article-title":"Physiological Levels of Glucagon Do Not Influence Lipolysis in Abdominal Adipose Tissue as Assessed by Microdialysis 1","volume":"86","author":"Gravholt","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2026.108278_bib258","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2019.110696","article-title":"Direct effects of glucagon on glucose uptake and lipolysis in human adipocytes","volume":"503","author":"Pereira","year":"2020","journal-title":"Mol. Cell. Endocrinol."},{"issue":"6","key":"10.1016\/j.phrs.2026.108278_bib259","doi-asserted-by":"crossref","DOI":"10.1007\/BF00257430","article-title":"The acute metabolic effects of glucagon and its interactions with insulin in forearm tissue","volume":"20","author":"Schneider","year":"1981","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.phrs.2026.108278_bib260","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nm.3761","article-title":"A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents","volume":"21","author":"Finan","year":"2015","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.phrs.2026.108278_bib261","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.cmet.2022.07.013","article-title":"LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept","volume":"34","author":"Coskun","year":"2022","journal-title":"Cell. Metab."},{"issue":"6","key":"10.1016\/j.phrs.2026.108278_bib262","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa2301972","article-title":"Triple\u2013Hormone-Receptor Agonist Retatrutide for Obesity \u2014 A Phase 2 Trial","volume":"389","author":"Jastreboff","year":"2023","journal-title":"New. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.phrs.2026.108278_bib263","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/S2213-8587(25)00092-0","article-title":"Effects of retatrutide on body composition in people with type 2 diabetes: a substudy of a phase 2, double-blind, parallel-group, placebo-controlled, randomised trial","volume":"13","author":"Coskun","year":"2025","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"7","key":"10.1016\/j.phrs.2026.108278_bib264","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1038\/s41591-024-03018-2","article-title":"Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial","volume":"30","author":"Sanyal","year":"2024","journal-title":"Nat. Med."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826001933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826001933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T13:55:13Z","timestamp":1785074113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661826001933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":264,"alternative-id":["S1043661826001933"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108278","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond weight loss: How metabolism in human adipocytes is shaped by GLP-1R agonists and dual GIPR\/GLP-1R agonists","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108278","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108278"}}